BIOMAT Database Logo BIOMAT Database Logo

[Absence of HIV 1/HTLV I "autochtonous" coinfection in the region of Nice]. 1992

J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica

UI MeSH Term Description Entries
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
HIV-1 and HTLV-I/II coinfection in Baltimore.
January 1992, Journal of acquired immune deficiency syndromes,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection.
April 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
Laboratory study of HIV-1 and HTLV-I/II coinfection.
October 1994, Journal of medical virology,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection.
March 2020, Pathogens (Basel, Switzerland),
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
Myelopathy and coinfection with HIV and HTLV-I.
October 1997, Neurology,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
HIV/HTLV-I coinfection and clinical grade at diagnosis.
January 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?
August 1998, AIDS patient care and STDs,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users.
January 1991, Journal of acquired immune deficiency syndromes,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.
May 1998, The Journal of experimental medicine,
J F Quaranta, and P Ferrari, and C Tirtaine, and F Sanderson, and R Follana, and J P Cassuto, and P Dellamonica
HIV and HTLV-1 coinfection: the need to initiate antiretroviral therapy.
January 2013, Journal of the International Association of Providers of AIDS Care,
Copied contents to your clipboard!